# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
NanoVibronix (NASDAQ:NAOV) reported quarterly losses of $(0.23) per share. This is a 65.67 percent increase over losses of $(0....
NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix," or the "Company"), a medical device company that produces the...
Distribution Partner, Delta Medical, Awarded a Five-Year Federal Supply Schedule Contract for PainShield by Department of Veter...
We are committed to our strategic vision of developing, improving and commercializing our distinct and effective therapies, whi...
Efforts Focused on Adding Therapeutic Functionality and Reducing CostsNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" ...